Product image of Lactulosa Biomedica (Lactulose) supplied by GNH India

Lactulosa Biomedica

Active Ingredient:
Lactulose
Origin:
EU

Lactulosa Biomedica (Lactulose)

Lactulose, the active ingredient in Lactulosa Biomedica, is an osmotic laxative presented as an oral formulation for oral use. It works by drawing water into the colon and reducing ammonia absorption, thereby relieving constipation and managing hepatic encephalopathy in adult patients.

GNH India supplies Lactulosa Biomedica as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across global markets. The company adheres to strict manufacturing standards and provides reliable logistics for timely delivery.

Manufacturer / TM Owner

Biomedica, Spol. S R.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lactulose is used to treat conditions related to bowel motility and ammonia metabolism.

  • Constipation: softens stool and promotes regular bowel movements by increasing colonic water content.
  • Chronic constipation: provides sustained symptom relief for patients with long‑term bowel irregularities.
  • Hepatic encephalopathy: lowers blood ammonia levels, helping improve mental status in patients with liver disease.

How It Works

  • Lactulose reaches the colon unchanged, where bacterial enzymes metabolize it into short‑chain fatty acids. This acidifies the colonic lumen, converting ammonia (NH3) to ammonium (NH4+), which is less readily absorbed. Simultaneously, the metabolites create an osmotic gradient that draws water into the intestinal lumen, softening stool and stimulating peristalsis.

Side Effects

Lactulose may be associated with several adverse reactions, ranging from mild to serious.

Common Side Effects

  • Abdominal cramping: discomfort due to increased colonic activity.
  • Flatulence: excess gas production from bacterial fermentation.
  • Diarrhea: loose stools from osmotic water influx.
  • Nausea: mild upset stomach.
  • Bloating: sensation of abdominal fullness.
  • Thirst: increased fluid loss.

Serious or Rare Side Effects

  • Severe dehydration: excessive fluid loss leading to low blood volume.
  • Electrolyte disturbances: notably hypokalemia from prolonged diarrhea.
  • Allergic reactions: rash, itching, or angioedema.
  • Colonic perforation: rare but life‑threatening injury to the bowel wall.

Precautions & Warnings

Lactulose should be used with caution in specific clinical situations.

  • Assess renal function: monitor patients with renal impairment for electrolyte changes.
  • Evaluate liver status: use cautiously in severe hepatic failure.
  • Monitor fluid balance: watch for dehydration, especially in elderly patients.
  • Adjust dose in pediatric patients only if prescribed by a qualified clinician.
  • Avoid in patients with known hypersensitivity to lactulose.
  • Store at ambient temperature: keep in the original container, protect from moisture.

Avoid Interactions

Lactulose can interact with other medicines, requiring attention to avoid reduced efficacy or increased risk.

Major Interactions (Avoid)

  • Antidiarrheal agents (e.g., loperamide): may counteract lactulose’s laxative effect.
  • Antibiotics that alter gut flora (e.g., broad‑spectrum agents): can diminish lactulose metabolism and efficacy.

Moderate Interactions (Monitor Closely)

  • Mineral supplements (e.g., magnesium, calcium): may enhance osmotic activity and increase risk of diarrhea.
  • Diabetes medications: monitor blood glucose as lactulose fermentation can affect carbohydrate balance.
  • Proton‑pump inhibitors: may modify gastric pH and affect lactulose breakdown.

Frequently Asked Questions

Lactulosa Biomedica contains lactulose, an osmotic laxative indicated for the relief of constipation and for the management of hepatic encephalopathy in adults. It helps soften stool and reduces blood ammonia levels, supporting bowel regularity and liver‑related neurological symptoms.

Lactulose reaches the colon unchanged, where gut bacteria break it down into short‑chain fatty acids. This process acidifies the lumen, converting ammonia to ammonium, which is less absorbable, and creates an osmotic gradient that draws water into the colon, softening stool and stimulating peristalsis.

The appropriate dose of Lactulosa Biomedica is determined by the prescribing clinician based on the patient’s condition, age, renal and hepatic function, and response to therapy. Dosage may be adjusted over time to achieve the desired clinical effect.

Safety data for lactulose during pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by a qualified health professional.

To request Lactulosa Biomedica, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lactulose differs from agents such as polyethylene glycol (PEG) in that it is metabolized by colonic bacteria, providing both laxative and ammonia‑lowering effects. PEG primarily acts as a non‑absorbed polymer that retains water in the stool but does not affect ammonia levels, making lactulose the preferred choice for hepatic encephalopathy.

Lactulosa Biomedica should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture and direct sunlight to maintain stability. No refrigeration is required for this oral formulation.

The product is taken orally, usually dissolved in a small amount of water or other suitable liquid before ingestion. It can be taken with or without food, as directed by the prescriber, to ensure optimal absorption and effect.

Serious risks include severe dehydration, electrolyte imbalances such as hypokalemia, and rare allergic reactions that may present as rash, itching or swelling. Patients should be monitored for signs of these conditions, especially during high‑dose or prolonged therapy.

Lactulose should be avoided in individuals with known hypersensitivity to the drug, those with intestinal obstruction or perforation, and patients with severe renal impairment without close monitoring. Contra‑indications should be confirmed by a healthcare professional before initiating therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lactulose

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT